Korro Bio (KRRO) Times Interest Earned (2018 - 2026)
Korro Bio (KRRO) posted Times Interest Earned of -$0.9 for Q1 2026, up 99.82% on a QoQ basis from -$503.96 in Q4 2025, and up 99.28% year-over-year from -$0.45 in Q1 2025.
Korro Bio (KRRO) Times Interest Earned (2018 - 2026) Analysis & Trends
Korro Bio's Times Interest Earned history runs 9 years deep, the most recent figure standing at -$0.9 for Q1 2026.
- Quarterly Times Interest Earned rose 99.28% year-over-year to -$0.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.16 (up 96.76% YoY) and the FY2025 annual result came in at -$0.6, up 86.03% from the prior year.
- Times Interest Earned was -$0.9 for Q1 2026 at Korro Bio, up from -$503.96 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.32 in Q3 2024 and bottomed at -$6382.7 in Q3 2023.
- A 5-year average of -$817.94 and a median of -$26.96 in 2022 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned sank 33300.79% — and 2024, when it surged 99.99%.
- Korro Bio's Times Interest Earned stood at -$12.94 in 2022, then tumbled by 1979.02% to -$268.93 in 2023, then grew by 14.33% to -$230.4 in 2024, then plunged by 118.73% to -$503.96 in 2025, then surged by 99.82% to -$0.9 in 2026.
- Business Quant data shows KRRO's Times Interest Earned at -$0.9 in Q1 2026, -$503.96 in Q4 2025, and -$0.46 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | -0.90 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.90 |
| Dec 31, 2025 | -503.96 |
| Sep 30, 2025 | -0.46 |
| Jun 30, 2025 | -0.74 |
| Mar 31, 2025 | -125.10 |
| Dec 31, 2024 | -230.40 |
| Sep 30, 2024 | -0.32 |
| Jun 30, 2024 | -0.35 |
| Mar 31, 2024 | -107.27 |
| Dec 31, 2023 | -268.93 |
| Sep 30, 2023 | -6,382.67 |
| Jun 30, 2023 | -6,136.00 |
| Mar 31, 2023 | -70.73 |
| Dec 31, 2022 | -12.94 |
| Sep 30, 2022 | -19.11 |
| Jun 30, 2022 | -26.96 |
| Mar 31, 2022 | -18.13 |
| Dec 31, 2021 | -117.36 |
| Sep 30, 2021 | -1.90 |
| Jun 30, 2021 | -0.73 |